311 related articles for article (PubMed ID: 17344204)
1. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
Hessol NA; Pipkin S; Schwarcz S; Cress RD; Bacchetti P; Scheer S
Am J Epidemiol; 2007 May; 165(10):1143-53. PubMed ID: 17344204
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
3. Risk of cancer among women with AIDS in New York City.
Fordyce EJ; Wang Z; Kahn AR; Gallagher BK; Merlos I; Ly S; Schymura M; Chiasson MA
AIDS Public Policy J; 2000; 15(3-4):95-104. PubMed ID: 12189715
[TBL] [Abstract][Full Text] [Related]
4. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
5. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
[TBL] [Abstract][Full Text] [Related]
6. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
8. Risk of cancer among Hispanics with AIDS compared with the general population in Puerto Rico: 1987-2003.
Ramírez-Marrero FA; Smit E; De La Torre-Feliciano T; Pérez-Irizarry J; Miranda S; Cruz M; Figueroa-Vallés NR; Crespo CJ; Nazario CM
P R Health Sci J; 2010 Sep; 29(3):256-64. PubMed ID: 20799513
[TBL] [Abstract][Full Text] [Related]
9. A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.
Srisawat N; Avihingsanon A; Praditpornsilpa K; Jiamjarasrangsi W; Eiam-Ong S; Avihingsanon Y
Transplant Proc; 2008 Oct; 40(8):2677-9. PubMed ID: 18929833
[TBL] [Abstract][Full Text] [Related]
10. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
Cinti SK; Gandhi T; Riddell J
AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
[TBL] [Abstract][Full Text] [Related]
11. Cancer incidence in AIDS patients in Catalonia, Spain.
Galceran J; Marcos-Gragera R; Soler M; Romaguera A; Ameijide A; Izquierdo A; Borràs J; de Sanjosé S; Casabona J
Eur J Cancer; 2007 Apr; 43(6):1085-91. PubMed ID: 17349785
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approaches to AIDS-related malignancies.
Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
[TBL] [Abstract][Full Text] [Related]
13. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy.
Diamond C; Taylor TH; Im T; Miradi M; Anton-Culver H
Hematol Oncol; 2006 Sep; 24(3):139-45. PubMed ID: 16604565
[TBL] [Abstract][Full Text] [Related]
14. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
[TBL] [Abstract][Full Text] [Related]
15. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
Tserenpuntsag B; Kołacińska A; Jabłonowska E
Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
[TBL] [Abstract][Full Text] [Related]
16. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
17. Risk of malignant neoplasms after liver transplantation: a population-based study.
Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
[TBL] [Abstract][Full Text] [Related]
18. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
19. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
[TBL] [Abstract][Full Text] [Related]
20. Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters.
Cain LE; Cole SR; Chmiel JS; Margolick JB; Rinaldo CR; Detels R
Am J Epidemiol; 2006 Feb; 163(4):310-5. PubMed ID: 16371516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]